IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex reports fall in profits

6:03 AM MST | February 11, 2014 | Deepti Ramesh

Cambrex (East Rutherford, NJ) reports a 79.6% fall in net profits for the fourth quarter of 2013, ended 31 December, compared with the year-ago quarter, to $8.89 million. The results for the fourth quarter of 2012 include tax benefits of $37.6 million, Cambrex says. Net sales for fourth-quarter 2013 increased 47%, however, to $102.4 million, primarily because of higher sales of a recently approved branded active pharmaceutical ingredient (API) and controlled substances, partially offset by lower sales of generic and other branded APIs and products using the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa